Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
PHASE2
This phase II trial studies how well sirolimus and azacitidine works in tre...
BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia
PHASE2
This phase II trial studies how well azacitidine and venetoclax with or wit...
Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse
PHASE2
The purpose of this study is to learn if 5'-Azacitidine will help to lower ...
Status
Completed
Location
Memorial Sloan Kettering at Basking Ridge (Consent and Follow-up)